Interaction of antihypertensive drugs and rosuvastatin: focus on safety, efficiency and prospects

Interaction of antihypertensive drugs and rosuvastatin: focus on safety, efficiency and prospects

Arterial hypertension and dyslipidemia is a very frequent comorbid condition. Arterial hypertension and dyslipidemia are combined in 40-70% of patients. The statins is the basic drug in primary and secondary prevention of cardiovascular disease and in the reduction of cardiovascular complications. W...

Full description

Bibliographic Details
Main Authors:	E V Luchinina, O G Kompaniets, N V Kizhvatova
Format:	Article
Language:	Russian
Published:	IP Morozov P.V. 2017-12-01
Series:	Системные гипертензии
Subjects:	dyslipidemia rosuvastatin antihypertensive drugs
Online Access:	https://syst-hypertension.ru/2075-082X/article/viewFile/29590/pdf

Similar Items

Managing hypercholesterolemia and preventing cardiovascular events in elderly and younger Chinese adults: focus on rosuvastatin
by: Wang Z, et al.
Published: (2013-12-01)

Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia
by: Hae Won Jung, et al.
Published: (2023-09-01)

Efficacy and Safety of Coadministered Ezetimibe–Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial
by: Zhao-Yan Song, et al.
Published: (2023-03-01)

Comparison of efficacy and safety of fixed dose combination of rosuvastatin and choline fenofibrate to fixed dose combination of rosuvastatin and fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicentre clinical trial in Indian population
by: Hanmant Barkate, et al.
Published: (2018-01-01)

Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients with Dyslipidemia and Hypertension: A Multicenter Randomized Clinical Trial
by: Sungjoon Park, MD, et al.
Published: (2024-01-01)

A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy
by: Eun-Seok Jeon, et al.
Published: (2022-12-01)

Evaluation of a Clinically Relevant Drug–Drug Interaction Between Rosuvastatin and Clopidogrel and the Risk of Hepatotoxicity
by: Chen Ning, et al.
Published: (2021-09-01)

Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double‐blind, multicenter, therapeutic confirmatory, phase III clinical trial
by: Chan Joo Lee, et al.
Published: (2024-03-01)

Fixeddose combination of rosuvastatin + ezetimibe: ease of use, safety and efficacy
by: I. A. Alekseeva, et al.
Published: (2019-10-01)

The problem of choice: original drug or generic? Emphasis on rosuvastatin
by: O. A. Polyakova, et al.
Published: (2022-05-01)

Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report
by: Keiki Sakurama, et al.
Published: (2023-04-01)

The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case
by: O. V. Gaisenok, et al.
Published: (2022-11-01)

ADVANTAGES AND NOVELTY OF CLINICAL APPLICATION OF THE TRIPLE COMBINATION FOR ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA: ACE INHIBITOR PERINDOPRIL WITH ROSUVASTATIN AND INDAPAMIDE
by: M. L. Maksimov, et al.
Published: (2017-08-01)

Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects
by: Kim CH, et al.
Published: (2017-12-01)

Central blood pressure lowering effect of telmisartan‐rosuvastatin single‐pill combination in hypertensive patients combined with dyslipidemia: A pilot study
by: JungMin Choi, et al.
Published: (2021-09-01)

Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia
by: Catalin Mindrescu, et al.
Published: (2008-12-01)

COMBINED ANTIHYPERTENSIVE THERAPY IN REAL CLINICAL PRACTICE. FOCUS ON FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS (According to the Data of Outpatient Registries RECVASA and PROFILE)
by: S. Yu. Martsevich, et al.
Published: (2017-07-01)

Efficacy and safety of Mertenil (rosuvastatin) 40 mg in patients with familial hypercholesterolemia
by: M Yu Zubareva, et al.
Published: (2014-06-01)

THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY
by: V. V. Kukharchuk, et al.
Published: (2013-06-01)

ROSUVASTATIN AS A POSSIBLE TREATMENT FOR SUDDEN SENSORINEURAL HEARING LOSS
by: Nadeem Ul Haq, et al.
Published: (2019-12-01)

COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU
by: S. V. Povetkin, et al.
Published: (2018-07-01)

Effect and Safety of Rosuvastatin in Acute Ischemic Stroke
by: Ji Hoe Heo, et al.
Published: (2016-01-01)

Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia
by: Rhee MY, et al.
Published: (2020-11-01)

Hydrophilic Interaction Liquid Chromatography-Electrospray Ionization Mass Spectrometry for Therapeutic Drug Monitoring of Metformin and Rosuvastatin in Human Plasma
by: Nikolaos Antonopoulos, et al.
Published: (2018-06-01)

Rosuvastatin-Induced reversible rhabdomyolysis
by: Sangeeta Pradhan, et al.
Published: (2023-01-01)

Rosuvastatin induced photolocalized purpura
by: Marwa Thabouti, et al.
Published: (2022-09-01)

What drugs do hypertension patients take in clinical practice? Structure of antihypertensive drugs in a large siberian region
by: Y. I. Grinshtein, et al.
Published: (2016-12-01)

The use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia
by: D.D. Ivanov, et al.
Published: (2015-04-01)

High-intensity therapy: rationale, indications and safety issues. Prospects of rosuvastatin in clinical practice
by: M. G Bubnova
Published: (2017-12-01)

Safety and vasopressor effect of rosuvastatin in septic patients
by: Hanaa A. El Gendy, et al.
Published: (2014-07-01)

Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report
by: Wen Wang, et al.
Published: (2022-04-01)

The Effect of Rosuvastatin on the Liver Enzyme of NMRI Mouse
by: Atena Nehzati Asl, et al.
Published: (2022-05-01)

A comparative study of atorvastatin and rosuvastatin on lipid lowering efficacy in hyperlipidemic patients
by: Samia Haque Tonu, et al.
Published: (2018-03-01)

Lipid Profile and Antihypertensive Drugs
by: Abdul-Khader A. Abdul-Khader
Published: (2009-06-01)

Analysis of genetic aspects of therapy with Rosuvastatin
by: Samat Kozhakhmetov, et al.
Published: (2016-06-01)

ANTIHYPERTENSIVE DRUG THERAPY FOR HYPERTENSIVE DISORDERS IN PREGNANCY
by: Slobodan Jankovic, et al.
Published: (2008-10-01)

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes
by: Parson H
Published: (2010-01-01)

LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY)
by: N. M. Akhmedzhanov, et al.
Published: (2016-05-01)

Vascular age concept: role in assessing risk and choosing therapy
by: S. R. Gilyarevsky, et al.
Published: (2020-01-01)

New data on the use of rosuvastatin and acetylsalicyl acid for the prolongation of human life
by: M. V. Ezhov, et al.
Published: (2018-04-01)